✦ LIBER ✦

Adjuvant Irinotecan Regimens in Combination with Infusional 5-Fluorouracil/Leucovorin Fail to Improve Outcomes in Surgically Resected Colorectal Cancer

✍ Scribed by Preeta Tyagi; Edward Chu

Book ID: 119616916
Publisher: CIG Media Group, LP.
Year: 2005
Tongue: English
Weight: 869 KB
Volume: 5
Category: Article
ISSN: 1533-0028
DOI: 10.1016/s1533-0028(11)70170-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II study of irinotecan, 5-fluoro

Phase I/II study of irinotecan, 5-fluorouracil, andl-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancer

✍ Ayumu Goto; Yasuhide Yamada; Ayumu Hosokawa; Takashi Ura; Tatsuhiro Arai; Tetsuy 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 208 KB

Addition of Aflibercept to Fluorouracil,

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

✍ Van Cutsem, E.; Tabernero, J.; Lakomy, R.; Prenen, H.; Prausova, J.; Macarulla, 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 532 KB

Bevacizumab in combination with irinotec

Bevacizumab in combination with irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) in patients with metastatic colorectal cancer who were previously treated with oxaliplatin-containing regimens: a multicenter observational cohort study (TCTG 2nd-BV study)

✍ Toshikazu Moriwaki, Hideaki Bando, Atsuo Takashima, Kentaro Yamazaki, Taito Esak 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 238 KB

Irinotecan combined with 5-fluorouracil

Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival

✍ Kang, Eun Joo; Im, Seock-Ah; Oh, Do-Youn; Han, Sae-Won; Kim, Jin-Soo; Choi, In S 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 220 KB

Prognostic advantage of irinotecan dose

Prognostic advantage of irinotecan dose escalation according to uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) genotyping in patients with metastatic colorectal cancer treated with bevacizumab combined with 5-fluorouracil/leucovorin with irinotecan in a first-line setting

✍ Lu, Chien-Yu; Huang, Ching-Wen; Hu, Huang-Ming; Tsai, Hsiang-Lin; Huang, Chun-Mi 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 455 KB

Efficacy and safety of bevacizumab-based

Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: Final results from a randomised phase ii study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)

✍ Ducreux, M.; Adenis, A.; Pignon, J.-P.; François, E.; Chauffert, B.; Ichanté, J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 602 KB